Browsing by Author "Montero, Maria Milagro"

Sort by: Order: Results:

  • López Montesinos, Inmaculada; Domínguez-Guasch, A.; Gómez-Zorrilla, Silvia; Duran Jordà, Xavier, 1974-; Siverio, Ana; Arenas-Miras, María Del Mar; Montero, Maria Milagro; Sorli Redó, M. Luisa; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo (Elsevier, 2020)
    Objectives: To analyze the clinical and economic burden of community-acquired (CA) or community-onset healthcare-associated (COHCA) multidrug-resistant (MDR) infections requiring hospitalization. Methods: Case-control ...
  • Arenas Jiménez, María Dolores; Crespo Barrio, Marta; Pérez-Sáez, María José; Collado Nieto, Silvia; Redondo Pachón, María Dolores; Llinàs-Mallol, Laura; Montero, Maria Milagro; Villar García, Judit; Arias Cabrales, Carlos Enrique; Barbosa Puig, Francisco; Buxeda, Anna; Burballa Tàrrega, Carla, 1988-; Sans Atxer, Laia; Vázquez, Susana; Oliveras, Anna; Mir, Marisa; Outón González, Sara; Galceran Herrera, Isabel; Solà Porta, Eulàlia; Sierra Ochoa, Adriana; Barrios Barrera, Clara; Rodriguez García, Eva; Cao Baduell, Higinio (MDPI, 2020)
    The COVID-19 pandemic has led to frequent referrals to the emergency department on suspicion of this infection in maintenance hemodialysis (MHD) and kidney transplant (KT) patients. We aimed to describe their clinical ...
  • Sorli Redó, M. Luisa; Luque Pardos, Sònia; Li, Jian; Campillo Ambrós, Núria; Danés, Marc; Montero, Maria Milagro; Segura, Concepción; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo (Elsevier, 2019)
    Objectives: Optimal dosage regimens of colistin for the treatment of urinary tract infections (UTI) are unknown. Colistimethate sodium (CMS), the inactive prodrug of colistin, is mainly excreted in urine and converts to ...
  • Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; VanScoy, Brian; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Segura, Concepción; Pomar, Virginia; Rivera, Alba; Grau Cerrato, Santiago; Ambrose, Paul G.; Oliver, Antonio; Horcajada Gallego, Juan Pablo (Elsevier, 2019)
    Background: Extensively drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) and particularly P. aeruginosa high-risk clones, are of growing concern because treatment options are limited. For years, colistin monotherapy ...
  • Sorli Redó, M. Luisa; Luque Pardos, Sònia; Li, Jian; Rodríguez, Eva; Campillo Ambrós, Núria; Fernández, Xenia; Soldado, Jade; Domingo, Ignacio; Montero, Maria Milagro; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo (MDPI, 2019)
    Colistin is administered as its inactive prodrug colistimethate (CMS). Selection of an individualized CMS dose for each patient is difficult due to its narrow therapeutic window, especially in patients with chronic kidney ...
  • Crespo Barrio, Marta; Pérez-Sáez, María José; Redondo Pachón, María Dolores; Llinàs-Mallol, Laura; Montero, Maria Milagro; Villar García, Judit; Arias Cabrales, Carlos Enrique; Burballa Tàrrega, Carla, 1988-; Vázquez, Susana; Mir, Marisa; Sierra Ochoa, Adriana; Collado Nieto, Silvia; Barrios Barrera, Clara; Rodriguez García, Eva; Sans Atxer, Laia; Barbosa Puig, Francisco; Cao Baduell, Higinio; Arenas Jiménez, María Dolores; Güerri Fernández, Roberto; Horcajada Gallego, Juan Pablo; Pascual Santos, Julio (Wiley, 2020)
    The SARS-Cov-2 infection disease (COVID-19) pandemic has posed at risk the kidney transplant (KT) population, particularly the elderly recipients. From March 12 until April 4, 2020, we diagnosed COVID-19 in 16 of our 324 ...
  • Collado Nieto, Silvia; Arenas Jiménez, María Dolores; Barbosa Puig, Francisco; Cao Baduell, Higinio; Montero, Maria Milagro; Villar García, Judit; Barrios Barrera, Clara; Rodriguez García, Eva; Sans Atxer, Laia; Sierra Ochoa, Adriana; Pérez-Sáez, María José; Redondo Pachón, María Dolores; Coca, Armando; Maiques LLacer, José María; Güerri Fernández, Roberto; Horcajada Gallego, Juan Pablo; Crespo Barrio, Marta; Pascual Santos, Julio (Karger (S. Karger AG), 2020)
    Introduction: Chronic kidney disease (CKD) increases the risk of mortality during coronavirus disease 2019 (COVID-19) episodes, and some reports have underlined the high incidence and severity of this infection in dialysis ...
  • Pujol, Miquel; Montero, Maria Milagro; Carratalà, Jordi; MRSA Bacteremia (BACSARM) Trial Investigators (Oxford University Press, 2021)
    Background: We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis. Methods: A ...
  • Molas, Ema; Luque Pardos, Sònia; Retamero, A.; Echeverría Esnal, Daniel; Guelar Grinberg, Ana; Montero, Maria Milagro; Güerri Fernández, Roberto; Sorli Redó, M. Luisa; Lerma-Chippirraz, Elisabet; Villar García, Judit; Knobel Freud, Hernando (Taylor & Francis (Routledge), 2018)
    OBJECTIVES: Interactions between antiretroviral treatment (ART) and comedications are a concern in HIV-infected patients. This study aimed to determine the frequency and severity of potential drug-drug interactions (PDDIs) ...
  • Montero, Maria Milagro; Mir Fontana, M. Luisa; Sulleiro, Elena; Avalos Esquivel, J.L.; García López, E.; Molina-Morant, D.; López Montesinos, Inmaculada; Sorli Redó, M. Luisa; Veliz Espinosa, G.; Mounteis Oliva, E.; Crespo Barrio, Marta; Monge, I.; Horcajada Gallego, Juan Pablo; Grau Cerrato, Santiago; Pascual Santos, Julio (Elsevier, 2019)
    There is little published data on benznidazole dosing, or levels in cerebrospinal fluid. In this report, we describe the clinical course of an immunosuppressed patient with Chagas central nervous system involvement. He was ...
  • Montero, Maria Milagro; Hidalgo López, Carlota; López Montesinos, Inmaculada; Sorli Redó, M. Luisa; Barrufet González, Cristina; Villar García, Judit; Güerri Fernández, Roberto; Herranz, Milagros; Crespo Barrio, Marta; Arenas Jiménez, María Dolores; Pascual Santos, Julio; González Juanes, Cristina; Horcajada Gallego, Juan Pablo (MDPI, 2021)
    Introduction: The aim of this study was to analyze a nosocomial coronavirus disease 2019 (COVID-19) outbreak that occurred on a polyvalent non-COVID-19 ward at a tertiary care university hospital in Spain during the first ...
  • Albasanz-Puig, Adaia; Montero, Maria Milagro; Carratalà, Jordi; IRONIC study group (BMJ Publishing Group, 2019)
    INTRODUCTION: Pseudomonas aeruginosa (PA) has historically been one of the major causes of severe sepsis and death among neutropenic cancer patients. There has been a recent increase of multidrug-resistant PA (MDRPA) ...
  • Sorli Redó, M. Luisa; Luque Pardos, Sònia; Segura, Concepción; Campillo Ambrós, Núria; Montero, Maria Milagro; Esteve, Erika; Herrera, Sabina; Benito, Natividad; Álvarez Lerma, Francisco; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo (BioMed Central, 2017)
    Background: Colistin has a narrow therapeutic window with nephrotoxicity being the major dose-limiting adverse effect. Currently, the optimal doses and therapeutic plasma levels are unknown. Methods: Prospective observational ...
  • López-Medrano, Francisco; Pérez-Sáez, María José; Montero, Maria Milagro; Pascual Santos, Julio; Horcajada Gallego, Juan Pablo; Aguado, José María (Elsevier, 2018)
    OBJECTIVES: To assess the risk factors for development of late-onset invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT). METHODS: We performed a multinational case-control study that retrospectively ...
  • Montero, Maria Milagro; López Montesinos, Inmaculada; Knobel Freud, Hernando; Molas, Ema; Sorli Redó, M. Luisa; Siverio, Ana; Prim, Núri; Segura, Concepción; Duran Jordà, Xavier, 1974-; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo (MDPI, 2020)
    This study aimed to assess the impact of extensively drug-resistant (XDR) phenotype on mortality in Pseudomonas aeruginosa bacteremia. A retrospective cohort study was performed in a tertiary hospital from January 2000 to ...
  • Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque, Sonia; Sorlí, Luisa; Campillo Ambrós, Núria; López Montesinos, Inmaculada; Padilla, Eduardo; Prim, Núria; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo (American Society for Microbiology, 2021)
    Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective ...